Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20848510 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Infliximab

Indicates status has not been verified in more than two years